Within the limitations of the present study, it may be proposed that the levels of IL-1β, IL-6, and IFNγ in the WUS indicate the severity of OLP lesion and may be used in the future as assessment criteria for further treatment modalities. The gene discussed is IL1B; the disease is oral lichen planus.